| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/29/2007 | US7223760 Substituted triazole compounds |
| 05/29/2007 | US7223758 Such as (3S)-2-[3-[(phenylacetyl)amino]-1-oxopropyl]-N-[cyano(3-phenoxyphenyl)methyl]hexahydro-3-pyridazinecarboxamide; for treatment of osteoporosis, hypercalcaemia, osteoporosis, gingival disease, arthritis, Paget's disease, and bone cancer |
| 05/29/2007 | US7223755 Such as (2S,5S)-5-benzyl-6-hydroxy-2-(2-methylpropyl)-3-morpholinone, which has calpain inhibitory activity; for treating cataract or retinal ischemic disorder |
| 05/29/2007 | US7223751 Sulfonamide derivatives, intermediate thereof, its preparation methods, and pharmaceutical composition comprising the same |
| 05/29/2007 | US7223738 Inhibitors of Akt activity |
| 05/29/2007 | US7223399 administering the toxin directly to a blood vessel, especially following a cardiovascular procedure. |
| 05/29/2007 | US7223394 Human antibodies that bind human TNFα |
| 05/29/2007 | US7223391 Administering subject's modified blood on consecutive days; blood is modified extracorporeally by exposure from 2 to 5 minutes to a combination of stressors; treating ischemic stress, atherosclerosis and rheumatoid arthritis |
| 05/29/2007 | US7223388 Reoviridae virus is conjugated to a hydroxylated hydrocarbon or a polycationic polymer to reduce the clearance and immunogenicity; antiproliferative disorders |
| 05/29/2007 | CA2338324C Stabilized carvedilol injection solution |
| 05/28/2007 | CA2569326A1 Compositions and methods to create a vascularized environment for cellular transplantation |
| 05/24/2007 | WO2007059515A2 Compositions of lipoxygenase inhibitors |
| 05/24/2007 | WO2007059431A1 Use of an omega-3 lipid-based emulsion following ischemic injury to provide protection and recovery in human organs |
| 05/24/2007 | WO2007059039A1 Thyroxine derivatives for preconditioning against stroke |
| 05/24/2007 | WO2007058634A1 Stable formulation of amorphous perindopril salts, a process for their preparation, especially industrial preparation, and their use in the therapy of hypertension |
| 05/24/2007 | WO2007058346A1 HETEROCYCLIC COMPOUND HAVING INHIBITORY ACTIVITY ON 11-β-HYDROXYSTEROID DEHYDROGENASE TYPE I |
| 05/24/2007 | WO2007058322A1 Basic group-containing compound and use thereof |
| 05/24/2007 | WO2007057687A1 Piperazine derivatives and their use in therapy |
| 05/24/2007 | WO2007057181A1 Use of aza-phenylalanine compounds for treating cardiac arrhythmia |
| 05/24/2007 | WO2007037513A9 Aryl-substituted nitrogen-containing heterocyclic compound |
| 05/24/2007 | WO2007031557A3 Alcanoic acid amides substituted by saturated o-heterocycles |
| 05/24/2007 | WO2007016352A3 Oral liquid losartan compositions |
| 05/24/2007 | WO2006042150A8 Diaminoalkane aspartic protease inhibitors |
| 05/24/2007 | US20070117843 Quinoline inhibitors of cGMP phosphodiesterase |
| 05/24/2007 | US20070117842 Polymorph of 4-[3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy]-7-methoxy-6- quinolinecarboxamide and a process for the preparation of the same |
| 05/24/2007 | US20070117807 Potassium channel modulators; cardiovascular disorders; antiarrhythmia agents; synthesis |
| 05/24/2007 | US20070117799 Oxabispidine compounds useful in the treatment of cardiac arrhythmias |
| 05/24/2007 | US20070117790 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
| 05/24/2007 | US20070117787 N-[(3R,5S)-1-(3-Acetoxy-2,2-dimethylpropyl)-7-chloro-5-(2,3-dimethoxyphenyl)-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepine-3-acetyl]piperidine-4-acetic acid; in combination with a statin, lowering cholesterol-level and lowering triglyceride-level |
| 05/24/2007 | US20070117758 Treating treating angiogenic disease, e.g., cancer, by administering therapeutically effective amount of compounds of the invention, for example, {(3R, 4S, 5S, 6R)-5-Methoxy-4-[(2R, 3R)-2-methyl-3-(3-methyl-but-2-enyl)-oxiranyl]-1-oxa-spiro[2.5]oct-6-yloxycarbonylamino}-3-methyl-butyric acid methyl ester |
| 05/24/2007 | US20070117754 Nectin polypeptides, polynucleotides, methods of making and use thereof |
| 05/24/2007 | US20070117742 producing a fraction enriched in a proteinaceous molecule having N-linked glycans comprising sialyl-Lewis X, Lewis X or LacdiNac structures; cerebral ischemia or myocardial infarction; composition comprising erythropoietin molecules |
| 05/24/2007 | US20070117142 Regulation of novel human asparagine-hydroxylases |
| 05/24/2007 | US20070117091 Anti-candida agents for the treatment of prion diseases |
| 05/24/2007 | US20070116708 Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof |
| 05/24/2007 | US20070116692 Host cells obtained by introducing and expressing VHL gene in cancer cells or embryonic stem cells |
| 05/24/2007 | US20070116688 Methods of organ regeneration |
| 05/24/2007 | US20070116685 Endothelial progenitor cells that express CD31 and c-kit, and not more than one percent express Tie-2 antigen; cell therapy for eye disorders |
| 05/24/2007 | US20070116674 Use of adipose tisue cells for initiating the formation of a fuctional vascular network |
| 05/24/2007 | CA2630200A1 Uses for camki i and hdacs in the treatment of heart conditions |
| 05/24/2007 | CA2628630A1 Compositions of lipoxygenase inhibitors |
| 05/23/2007 | EP1788092A1 Method of inhibiting postischemic reperfusion-induced cell death and cell death inhibitor |
| 05/23/2007 | EP1788086A1 Death Domain Containing Receptor 5 |
| 05/23/2007 | EP1788000A1 Agent for preventing and ameliorating obesity |
| 05/23/2007 | EP1787992A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
| 05/23/2007 | EP1787984A2 Azacyclic compounds for use in the treatment of serotonin related diseases |
| 05/23/2007 | EP1787970A1 Method of obtaining polyphenolic extracts from cocoa beans, the extracts obtained and their applications |
| 05/23/2007 | EP1786835A2 Antiangiogenic compounds, pharmaceutical composition containing said compounds and the use thereof |
| 05/23/2007 | EP1786814A1 Bicyclononene derivatives as renin inhibitors |
| 05/23/2007 | EP1786786A1 Adamantyl derivates as p2x7 receptor antagonists |
| 05/23/2007 | EP1786467A1 Method of enhancing absorptions of transmucosal administration formulations |
| 05/23/2007 | EP1786436A2 Method for improving ventilatory efficiency |
| 05/23/2007 | EP1786435A1 Combination therapies employing vitamin b6 related compounds and ace inhibitors and uses thereof for the treatment of diabetic disorders |
| 05/23/2007 | EP1786428A2 Pde5 inhibitor compositions and methods for treating cardiac indications |
| 05/23/2007 | EP1786414A2 Novel statin pharmaceutical compositions and related methods of treatment |
| 05/23/2007 | EP1786265A2 Novel compositions and methods of treatment |
| 05/23/2007 | EP1655055B1 Use of dapsone as a neuroprotector in cerebral infarction |
| 05/23/2007 | EP1587584B1 Pharmaceutical combination for the prophylaxis or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases |
| 05/23/2007 | EP1442040B1 Bridged bicycle (1,4) benzodiazepine vasopressin receptor antagonists |
| 05/23/2007 | EP1423384B1 Pyridine derivatives as raf kinase inhibitors |
| 05/23/2007 | EP1385548B1 Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions |
| 05/23/2007 | EP1272454B1 Method for synthesis of n-[ (s)-1-carboxybutyl]-(s)-alanine esters and use in synthesis of perindopril |
| 05/23/2007 | EP1254895B1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 05/23/2007 | EP1253929B1 Use of relaxin to treat diseases related to vasoconstriction |
| 05/23/2007 | EP1237845B1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
| 05/23/2007 | EP1181014B1 HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND METHOD |
| 05/23/2007 | EP1097141B1 Imidazole derivatives with biphenylsulfonyl substitution, method for preparing them and their use as a drug or diagnostic agent |
| 05/23/2007 | EP1019074B1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 05/23/2007 | EP0948335B1 Methods of treating or preventing cardiac arrhythmia |
| 05/23/2007 | CN1968957A Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmias |
| 05/23/2007 | CN1968956A Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmias |
| 05/23/2007 | CN1968932A Processes for preparing 6-alkyl-5-arylsulfonyl-dihydrophenanthridines |
| 05/23/2007 | CN1968929A Substituted tetrahydro-2h-isoquinolin-1-one derivatives, method for the production thereof, and use of the same as medicaments |
| 05/23/2007 | CN1968693A Medicine comprising combination of acetylcholine esterase inhibitor and 5-substituted 3-oxadiazolyl-1,6-naphthyridin-2(1H)-one derivative |
| 05/23/2007 | CN1966519A Hydrated perindopril salt, preparation method thereof and composition containing the same |
| 05/23/2007 | CN1966512A Dwarf lilyturf polysaccharide MDG-1 sulfated derivative, its preparation method and uses |
| 05/23/2007 | CN1966481A Red sage root water-soluble extract salt and its preparing process |
| 05/23/2007 | CN1966070A Application of edestin in preparation of medicament |
| 05/23/2007 | CN1966050A Medicament for treating heart disease and preparation process thereof |
| 05/23/2007 | CN1966048A Chinese medicinal formulation for treating apoplexy sequelae |
| 05/23/2007 | CN1966004A Medicament for treating cerebrovascular and cardiovascular disease and apoplexy sequelae |
| 05/23/2007 | CN1965996A Preparation method of Chinese medicinal capsule for treating apoplexy |
| 05/23/2007 | CN1965995A Medicament for treating coronary heart disease and senile deficiency syndrome and preparation process thereof |
| 05/23/2007 | CN1965991A Chinese medicinal formulation for treating spermophlebectasia |
| 05/23/2007 | CN1965986A Medicinal decoction for treating viral myocarditis and method for preparing same |
| 05/23/2007 | CN1965970A Medicament for treating cardiovascular and cerebrovascular diseases |
| 05/23/2007 | CN1965967A Liquid having favorable effect on the treatment of hypertensive cerebral hemorrhage |
| 05/23/2007 | CN1965966A Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases, preparation method and application thereof |
| 05/23/2007 | CN1965941A Medicated tea for treating piles |
| 05/23/2007 | CN1965936A Prescription of qi and blood harmonizing liquid and preparation process thereof |
| 05/23/2007 | CN1965935A Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases, formulation thereof, preparation method and application thereof |
| 05/23/2007 | CN1965933A Medicated tea for lowering blood pressure and method for preparing same |
| 05/23/2007 | CN1965926A Pharmaceutical composition for treating cardiovascular and cerebrovascular diseases, preparation method and application thereof |
| 05/23/2007 | CN1965924A Medicament for lowering blood fat and dilating coronary artery |
| 05/23/2007 | CN1965923A Pharmaceutical composition for treating cardiovascular and cerebrovascular diseases, preparation method and application thereof |
| 05/23/2007 | CN1965922A Pharmaceutical composition for treating cardiovascular and cerebrovascular diseases, preparation method and application thereof |
| 05/23/2007 | CN1965921A Pharmaceutical composition for treating cardiovascular and cerebrovascular diseases, preparation method and application thereof |
| 05/23/2007 | CN1965920A Pharmaceutical composition for treating cardiovascular and cerebrovascular diseases, preparation method and application thereof |
| 05/23/2007 | CN1965919A Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases, preparation method and application thereof |
| 05/23/2007 | CN1965917A Capsule consisting of five kinds of ingredients for treating piles and method for preparing same |